Abstract
Laboratory studies with the trichomonacidal agent, metronidazole, show that 66 strains of T. vaginalis were killed in three days by concentrations of 0·0625 μg./ml. to 1 μg./ml.
Estimations of serum and urine levels in nine volunteers, the serum levels in 31 women, and the urine levels in 33 women show that metronidazole is rapidly absorbed and excreted in high concentration in the urine.
Development of resistance to metronidazole by T. vaginalis has not been demonstrated either in vivo or in vitro.
No toxic effect was demonstrated in the blood, liver, or kidney.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BUSHBY S. R., COPP F. C. The antitrichomonal activity of amidonitrothiazoles. J Pharm Pharmacol. 1955 Feb;7(2):112–117. doi: 10.1111/j.2042-7158.1955.tb12014.x. [DOI] [PubMed] [Google Scholar]
- CATTERALL R. D., NICOL C. S. Systemic treatment of trichomonal infections. Br Med J. 1957 Jul 6;2(5035):29–31. doi: 10.1136/bmj.2.5035.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- COSAR C., JULOU L. Activité de l'(hydroxy-2'éthyl)-1 méthyl-2 nitro-5 imidazole (8.823 R. P.) vis-à-vis des infections expérimentales à Trichomonas vaginalis. Ann Inst Pasteur (Paris) 1959 Feb;96(2):238–241. [PubMed] [Google Scholar]
- DUNLOP E. M., PHILIPP E., WATT J. D. Oral treatment of trichomonal vaginitis with 2-acetylamino-5-nitrothiazole (tritheon). Br J Vener Dis. 1958 Mar;34(1):57–57. doi: 10.1136/sti.34.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DUREL P., ROIRON V., SIBOULET A., BOREL L. J. Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 RP. Br J Vener Dis. 1960 Mar;36:21–26. doi: 10.1136/sti.36.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JENNISON R. F., STENTON P. Sensitivity of Candida strains to nystatin. J Clin Pathol. 1957 Aug;10(3):219–221. doi: 10.1136/jcp.10.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MOFFETT M., MCGILL M. I. Treatment of trichomoniasis with metronidazole. Br Med J. 1960 Sep 24;2(5203):910–911. doi: 10.1136/bmj.2.5203.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PLENTL A. A., GRAY M. J., NESLEN E. D., DALALI S. J. The clinical evaluation of 2-acetylamino-5-nitro-thiazole, an orally effective trichomonacide. Am J Obstet Gynecol. 1956 Jan;71(1):116–120. doi: 10.1016/0002-9378(56)90686-x. [DOI] [PubMed] [Google Scholar]
- REES E. Systemic treatment of Trichomonas vaginalis infestation in women. A preliminary report. Br Med J. 1960 Sep 24;2(5203):906–909. doi: 10.1136/bmj.2.5203.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STENTON P. The isolation of Trichomonas vaginalis. J Med Lab Technol. 1957 Oct;14(4):228–230. [PubMed] [Google Scholar]
- WATT L., JENNISON R. F. Clinical evaluation of metronidazole. A new systemic trichomonacide. Br Med J. 1960 Sep 24;2(5203):902–905. doi: 10.1136/bmj.2.5203.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILLCOX R. R. Treatment of vaginal trichomoniasis with 2-acetylamino-5-nitrothiazole (aminitrozole) given orally. Br J Vener Dis. 1957 Jun;33(2):115–117. doi: 10.1136/sti.33.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]